The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated Radiation
Jonathan Tward, Lauren Lenz, Darl D. Flake, Saradha Rajamani, Paul Yonover, Carl Olsson, Deepak A. Kapoor, Constantine Mantz, Stanley L. Liauw, Tatjana Antic, Michael Fabrizio, Daniel Salzstein, Neal Shore, Dan Albertson, Jonathan Henderson, Steve P. Lee, Hiram A. Gay, Jeff Michalski, Arthur Hung, David RabenIsla Garraway, Michael S. Lewis, Paul L. Nguyen, David T. Marshall, Michael K. Brawer, Steven Stone, Todd Cohen
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated Radiation'. Together they form a unique fingerprint.